Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Xpel Inc.

Start price
Target price
Perf. (%)
€44.00
25.01.21
-
25.01.22
7.27%
09.02.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
buy
Sunworks Inc.

Start price
Target price
Perf. (%)
€19.80
25.01.21
€25.00
25.01.22
-88.49%
17.01.22

Revenue growth >5% per year expected
Top 10 in its market
Small cyclical dependencies
Known brand
buy
Royal Helium Ltd.

Start price
Target price
Perf. (%)
€0.50
24.01.21
€1.00
24.01.22
-53.12%
25.01.22

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
buy
Americas Gold & Silver Corp.

Start price
Target price
Perf. (%)
€2.19
23.01.21
-
23.01.22
-68.55%
24.01.22

Could be very worthwhile Investment >20% year
Future proof or reliable business model
Revenue growth >5% per year expected
Innovative
buy
Innocan Pharma Corp.

Start price
Target price
Perf. (%)
€0.31
23.01.21
€6.00
23.01.22
33.11%
24.01.22

Could be very worthwhile Investment >20% year
buy
Ynvisible Interactive

Start price
Target price
Perf. (%)
€1.19
23.01.21
€10.00
23.01.22
-86.60%
24.01.22

Could be very worthwhile Investment >20% year
buy
STS Group AG

Start price
Target price
Perf. (%)
€6.98
23.01.21
-
23.01.22
16.33%
24.01.22

Medium risks for its business
Some uniques
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Bilibili Inc.

Start price
Target price
Perf. (%)
€102.00
18.01.21
€80.00
18.04.21
-15.49%
18.04.21

High valuation
Very low/no dividend yield expected
Higher risks for its business
buy
Wirecard AG ADR

Start price
Target price
Perf. (%)
€0.21
17.01.21
€100.00
17.01.22
-90.38%
18.01.22

Could be very worthwhile Investment >20% year
Well known brand
Everfuel A/S

Start price
Target price
Perf. (%)
€14.04
13.01.21
€6.00
13.01.22
-68.83%
14.01.22

Very Future proof/growth oriented business model
Probably not worthwhile Investment
Very low/no dividend yield expected
Nicheplayer
buy
Mowi Asa

Start price
Target price
Perf. (%)
€17.52
13.01.21
€26.00
08.02.27
-3.97%
05.06.24

Could be worthwhile Investment >10% per year
Innovative
Stable Large shareholder and/or long term investor
Market Leader or Top 3
Reconnaissance Energy Afri.ltd

Start price
Target price
Perf. (%)
€1.69
12.01.21
-
12.01.22
214.20%
13.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
buy
Aileron Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.50
11.01.21
-
11.01.22
-6.67%
29.01.21

Could be worthwhile Investment >10% per year
Good culture
Innovative
Growths slower than the competition
buy
Sunworks Inc.

Start price
Target price
Perf. (%)
€6.30
11.01.21
€17.00
11.01.22
139.68%
22.01.21

Revenue growth >5% per year expected
Top 10 in its market
Small cyclical dependencies
Known brand
buy
Comtec Solar Systems Group Ltd

Start price
Target price
Perf. (%)
€0.028
06.01.21
-
06.01.22
58.18%
25.10.21

buy
Medmen Enterprises Inc.

Start price
Target price
Perf. (%)
€0.12
05.01.21
€8.00
05.01.22
24.70%
06.01.22

Capable Management
Known brand
Future proof or reliable business model
buy
Appen Ltd.

Start price
Target price
Perf. (%)
€16.20
01.01.21
€23.00
01.01.22
-63.58%
24.09.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Higher EBIT margin than peer group
buy
BioVaxys Technology Corp.

Start price
Target price
Perf. (%)
€0.13
30.12.20
€5.00
30.12.21
9.92%
31.12.21

Could be very worthwhile Investment >20% year
Strong uniques
Very Future proof/growth oriented business model
Leading role in innovation
Rainforest Resources Inc.

Start price
Target price
Perf. (%)
€1.61
28.12.20
€1.00
-6.21%
29.12.20

Risky Investment
Business model of the past or high risk
Little known brand
buy
Westwing Group AG

Start price
Target price
Perf. (%)
€31.42
25.12.20
€48.60
25.12.21
-29.59%
26.12.21

Could be worthwhile Investment >10% per year
buy
Metro AG

Start price
Target price
Perf. (%)
€9.35
25.12.20
€11.00
-
29.01.23

Could be worthwhile Investment >10% per year
Ocugen Inc.

Start price
Target price
Perf. (%)
€0.60
22.12.20
-
22.12.21
1408.67%
07.11.21

Probably not worthwhile Investment
buy
Equillium Inc.

Start price
Target price
Perf. (%)
€3.82
21.12.20
€6.00
21.12.21
3.14%
20.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
buy
Christina Lake Cannabis Corp.

Start price
Target price
Perf. (%)
€0.49
19.12.20
€1.00
19.12.21
-65.57%
20.12.21

Could be very worthwhile Investment >20% year
Mereo Biopharma Group Ltd.

Start price
Target price
Perf. (%)
€2.74
18.12.20
-
18.12.21
-45.99%
19.12.21

Probably not worthwhile Investment